# Hivemind Capital Partners

> Hivemind Capital Partners is a VC fund backing Financial Services. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 45
- Last investment: Jun 2026
- Lead investor: 49%
- Last fund: Jun 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hivemindcapital/
- Website: http://www.hivemindcapital.co/

Hivemind Capital Partners is a blockchain-focused investment business. It specializes in the fields of cryptocurrency, blockchain, and financial services. Hivemind Capital Partners was founded in 2021 and headquartered in New York, United States.

## Contacts

5 contacts available for Hivemind Capital Partners. Shizune tracks 2 team members at Hivemind Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hivemind-capital-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.1M–$7M |
| Pre-Seed | $1M–$2.4M |
| Post-IPO Equity | $100M–$558M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Financial Services | 12 | 27% |
| Blockchain | 11 | 24% |
| Bitcoin | 10 | 22% |
| FinTech | 7 | 16% |
| Software | 5 | 11% |

62 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 20 | 44% |
| Pre-Seed | 5 | 11% |
| Post-IPO Equity | 5 | 11% |
| Venture - Series Unknown | 5 | 11% |
| Series A | 3 | 7% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 24 | 53% |
| United Kingdom | 3 | 7% |
| Canada | 2 | 4% |
| Hong Kong | 2 | 4% |
| Nigeria | 1 | 2% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Matt Zhang | Founder and Managing Partner | 5 | https://shizune.co/investors/profile/matt-zhang-19f1 |
| Sam Peurifoy | Partner | 1 | https://shizune.co/investors/profile/sam-peurifoy |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Daya | Daya Labs operates a unified financial infrastructure that integrates stablecoin rails, real-time foreign exchange, and modern treasury systems. The platform enables enterprise clients to process global business payouts, manage multi-currency balances, and settle international cross-border transactions using local fiat and digital currencies. | $2.4M | Pre-Seed | Jun 24, 2026 |  |
| RDC | Receipts Depositary Corporation (RDC) provides a platform for investing in digital and alternative assets. The company leverages the Depositary Receipt (DR) structure to simplify the investment process. RDC does not operate or hold assets directly but facilitates investments through its platform. The company focuses on making it easier forinvestors to access a variety of asset classes, including cryptocurrencies and other digital assets. | $7M | Seed | Jun 16, 2026 |  |
| Upexi | Upexi is a multi-faceted brand owner that focuses on direct-to-consumer and Amazon brands. The company pursues organic growth for its present brands while operating in sectors with high growth trends. The objective of Upexi is to keep gathering consumer information and develop a sizable client database across all markets we serve. | $36M | Post-IPO Debt | Jan 13, 2026 |  |
| Zynk | Zynk is a fintech company that offers global payments and liquidity infrastructure. | $5M | Seed | Nov 04, 2025 |  |
| AgriFORCE | AgriFORCE develops technologies and solutions to improve sustainable farming. It provides digital tools to create growing systems, indoor hydroponics, and micropropagation. AgriFORCE is based in Vancouver, Canada. | $214.4M | Post-IPO Equity | Oct 27, 2025 |  |
| Fleak | Fleak is a serverless API builder tailored for creating AI data workflows effortlessly. It enables users to quickly develop and deploy API backends with a single click. Leveraging a low-code workflow builder, Fleak simplifies request payload manipulation using SQL, integrates seamlessly with LLM or embedding models, and supports invoking AWS Lambdafunctions. Fleak excels in handling parallelization and concurrency, automatically optimizing performance for high throughput across all nodes. This ensures scalable and reliable API deployment without requiring users to manage multithreading or load balancing. Outputs can be delivered directly via synchronous HTTP responses or forwarded to third-party data storage systems like Snowflake and Pinecone, making Fleak production-ready for enterprise applications. | $6M | Seed | Oct 01, 2025 |  |
| TON Strategy Company | VERB Technology Company is a software-as-a-Service, or SaaS, applications platform developer. Its platform is comprised of sales enablement business software products marketed on a subscription basis. The applications are available in both mobile and desktop versions. It includes verbCRM, Customer Relationship Management application, verbLEARN,Learning Management System application, and verbLIVE, its Live Broadcast Video Webinar application. | $558M | Post-IPO Equity | Aug 04, 2025 |  |
| RD Technologies | RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses. | $40M | Series A | Jul 30, 2025 |  |
| Fundamental Global | Fundamental Global is a reinsurance and investment management holding company focused on opportunistic collateralized and loss capped reinsurance, while allocating capital in partnership with Fundamental Global® to SPAC and SPAC sponsor-related businesses. | $200M | Post-IPO Equity | Jul 30, 2025 |  |
| Lite Strategy | MEI Pharma, Inc. (Nasdaq: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The Company’s clinical development pipeline includes lead drug candidate Pracinostat, a potential best-in-class, oral histone deacetylase (HDAC) inhibitor. Pracinostat has been tested in more than 150 patients inmultiple Phase I and exploratory Phase II clinical trials, including advanced hematologic malignancies such as myelodysplastic syndrome, acute myeloid leukemia and myelofibrosis. The Company expects to initiate a randomized Phase II trial of Pracinostat in combination with standard-of-care in at least one hematologic malignancy toward the middle of 2013. In addition, MEI Pharma is developing two drug candidates derived from its isoflavone-based technology platform, ME-143 and ME-344. Results from a Phase I trial of intravenous ME-143 in heavily treated patients with solid refractory tumors were presented at the American Society of Clinical Oncology Annual Meeting in June 2012. A Phase I clinical trial of intravenous ME-344 in patients with solid refractory tumors is ongoing. | $100M | Post-IPO Equity | Jul 18, 2025 |  |

10 of 45 investments shown.

## Co-investors
- [Concentric](https://shizune.co/investors/profile/concentric) — VC Fund, 4 deals together
- [Kingsway Capital](https://shizune.co/investors/profile/kingsway-capital) — VC Fund, 4 deals together
- [ParaFi Capital](https://shizune.co/investors/profile/parafi-capital) — VC Fund, 4 deals together
- [Timechain](https://shizune.co/investors/profile/timechain-f403) — VC Fund, 4 deals together
- [Tykhe Ventures](https://shizune.co/investors/profile/tykhe-block-ventures) — VC Fund, 4 deals together
- [Arrington Capital](https://shizune.co/investors/profile/arrington-capital-9858) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Galaxy Interactive](https://shizune.co/investors/profile/galaxy-interactive) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [PeopleFund](https://shizune.co/investors/profile/peoplefund) — VC Fund
- [Cacao Capital](https://shizune.co/investors/profile/cacao-capital) — VC Fund
- [Draper University Ventures](https://shizune.co/investors/profile/draper-university-ventures) — VC Fund

## Featured in investor lists
- [FinTech Investors in Hong Kong](https://shizune.co/investors/fintech-investors-hong-kong)
- [Finance Investors in Hong Kong](https://shizune.co/investors/finance-investors-hong-kong)
- [Finance VC Funds in Hong Kong](https://shizune.co/investors/finance-vc-funds-hong-kong)
- [Financial Services VC Funds in Hong Kong](https://shizune.co/investors/financial-services-vc-funds-hong-kong)
- [All Investors in Guatemala](https://shizune.co/investors/investors-guatemala)
- [All VC Funds in Guatemala](https://shizune.co/investors/vc-funds-guatemala)

## FAQ

### What does Hivemind Capital Partners invest in?

Hivemind Capital Partners invests primarily in Financial Services, Blockchain and Bitcoin startups, most often at Seed and Pre-Seed stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Hivemind Capital Partners's check size?

Hivemind Capital Partners typically joins rounds of $2.1M–$7M at Seed, $1M–$2.4M at Pre-Seed and $100M–$558M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hivemind Capital Partners participates in.

### How do I contact Hivemind Capital Partners?

Public channels for Hivemind Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hivemind Capital Partners?

The team at Hivemind Capital Partners includes Matt Zhang (Founder and Managing Partner) and Sam Peurifoy (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co